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BasicScienceGut Permeability and Glucose Absorption Are
Affected at Early Stages of Graft Rejection
in a Small Bowel Transplant Rat Model
Pablo Stringa, PhD,1,2,3 DavidRomanin,1 Natalia Lausada,2 RodrigoPapaGobbi,1 Carolina Zanuzzi,4 PedroMartín,1
Juan Cruz Abate,2 Ana Cabanne,5 Nathalie Arnal,6 Leandro Vecchio,2 Verónica Milesi,1 Enrique Portiansky,4
Gabriel Gondolesi,3,5 and Martin Rumbo1Background. Intestinal transplantation (ITx) faces many challenges due to the complexity of surgery and to the multiple immu-
nological reactions that lead to the necessity of rigorous follow-up for early detection of acute cellular rejection (ACR). Our aim was
to determine the kinetics of ACR using an experimental ITx model, with emphasis in the characterization of the process using
different approaches, including the use of functional assays of absorptive and barrier function.Methods. ITx in rats conducting
serial sampling was performed. Clinical monitoring, graft histology, proinflammatory gene expression, and nitrosative stress determi-
nation were performed. Also, glucose absorption, barrier function using ovalbumin translocation, and contractile function were ana-
lyzed. Results. The model used reproduced the different stages of ACR. Allogeneic ITx recipients showed signs of rejection from
postoperative day (POD) 5, with increasing severity until 12 POD. Histological evaluation showed mild rejection in early sampling and
severe rejection at late stages, with alterations in all graft layers. IL-6, CXCL 10, IFNg, and nitrite plasmas levels showed behavior
coincident with histopathology. Remarkably, allogeneic grafts showed a marked alteration of glucose absorptive capacity from
POD 5 that was sustained until endpoint. Coincidently, barrier function alteration was evidenced by luminal ovalbumin translocation
to serum. Contractile function was progressively impaired along ACR.Conclusions.Glucose absorption and barrier function are
altered at early stages of ACR when histological alterations or gene expression changes were much subtle. This observation may
provide simple evaluation tools that could be eventually translated to the clinics to contribute to early ACR diagnosis.
(Transplantation Direct 2017;3:e220; doi: 10.1097/TXD.0000000000000718. Published online 6 October, 2017.)Intestinal transplantation (ITx) faces many challenges, due tothe complexity of the surgical technique, the multiple im-
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2 Transplantation DIRECT ■ 2017 www.transplantationdirect.comas to improve our knowledge on ITx biology.2 By far, rat ITx
models has been the most extensively used mainly as conse-
quence of technical aspects and the availability of different
strains.3 Since the standardization of procedures in the last
decade of the XXth. century, orthotopic ITx and heterotopic
ITx (HITx) variants of ITx are used, each of them allowing
the evaluation of different aspects of the process.4,5 Despite
HITx models do not reproduce the physiological anatomy
of an orthotopic procedure, they are commonly used to study
immunological reactions because they have the advantages
of being technically easy, having higher survival rate, and
allowing serial sampling of the graft. TheHITx has been used
to establish the proof of concept of different immune modu-
lation strategies to avoid rejection, as well as to study immu-
nological reactions involved in graft rejection.6-10
We here report the use of a HITx model to study the
impact of the initial stages of acute cellular rejection
(ACR) on graft functional features, such as absorptive capacity,
barrier function, and motility. We analyzed the kinetics of
these variations in the context of the characterization of clin-
ical and molecular changes associated with the ACR process.
MATERIALS AND METHODS
Animal Use and Care
AdultWistar and Sprague-Dawleymale rats (averageweight,
220 ± 15 g) were housed in a climate-controlled room on a
12-hour light-dark cycle, fed with standard laboratory rats
chow, and allowed water ad libitum.Wistar rats were provided
by the Facultad de Ciencias Veterinarias of the Universidad
Nacional de La Plata (Argentina) animal facility and Sprague-
Dawley animals were provided by the Facultad de Ciencias
Veterinarias of the Universidad de Buenos Aires (Argentina).
All animals received human care, and the study protocols com-
plied with local guidelines for vertebrate animal welfare as well
as with USPHS and/or European Union policy on this matter.
Surgical Procedure and Experimental Protocol
HITx was performed under general anesthesia (isofluorane).
The surgical technique was like those previously described3
(Materials and Methods, SDC, http://links.lww.com/
TXD/A52).
Animals were divided into following groups per strain com-
bination: (1) isogenic (ISO) HITx group (Wistar as donor and
recipient) and (2) allogeneic (ALLO) HITx group (Sprague-
Dawley as donor, Wistar as recipient).
Intestinal graft was sampled from recipient distal stoma at
30 minutes, 3, 5, and 7 postoperative days (POD) after HITx and
at the end point of the experimental protocol (10-12 POD). Also,
blood samples from tail veinwere taken at 5, 7 and 10 to 12 POD.
Recipient and Graft Clinical Monitoring
Recipient clinical monitoring after HITx in search of pain
and/or discomfort signs was daily performed and quantified.
Ocular secretion, hair appearance, posture, attitude, and feces
production was considered as postsurgical discomfort signs.
Each recipient received a general score resulting from adding
each evaluated parameter (Figure S1, SDC, http://links.lww.
com/TXD/A52). Also, recipient body weight was daily eval-
uated. Graft monitoring by abdominal palpation was
performed every 24 hours. Graft tightening was considered
as a clinical indicator of ACR as previously described.Functional Evaluation of the Transplanted Intestine
To evaluate graft absorptive and barrier function, a solution
containing glucose (2 g/kg) and ovalbumin (OVA) (150 μg/
dose) diluted in 1.5-mL saline was administered by proximal
ostomy 5 and 10 days after ITX. Glycemia wasmeasured using
an Accu-Chek blood glucose meter (Roche) just before and 15,
30, 60, 90, 120, and 180 minutes after glucose administration.
Serum levels of OVAwere measured by competitive ELISA 30
and 90 minutes after administration as previously described.11
For both measurements, blood samples were obtained from the
receptor tail vein. Also, graft contractile function by isometric
graft force measurements was analyzed at 4 and 10 POD (Mate-
rials andMethods, SDC, http://links.lww.com/TXD/A52).
Histology and Immunohistochemistry
Histological analysis of transplanted intestines was per-
formed on hematoxylin-eosin–stained 5-μm tissue sections. All
samples were analyzed by experienced pathologist in a blinded
way. ACR was determined using 2 different scores previously
used in ITx animal models.12,13 Also, ischemia-reperfusion
damage using Park score were determined.14 Besides, a descrip-
tive evaluation of each intestinal graft layer in search for histo-
logical alterations was performed.
An immunohistochemical study to evaluate apoptosis was
performed by Tunel technique using the In-Situ Cell Death
TMR (Roche) following manufacturer's instructions. Counting
of apoptotic cells was performed considering the number of ap-
optotic cells in 10 fields per sample using a confocal microscope
(Olympus FV1000). Apoptotic cellswere initially counted in the
whole wall of the graft. Subsequently, the total number of cells
observed in each sample was classified per their location in the
transplanted intestine (lamina propria, crypts or intestinal
epithelium compartment).
Collagen Determination
Collagen evaluation was done in sections stained with the
Picrosirius red technique and viewed with polarized light
(Montes, 1996). For this purpose, sections were deparaffinized,
hydrated through graded ethanol and stained for 1 hour in a
0.1%solution of SiriusRed (Direct Red 80; Aldrich,Milwaukee,
WI) dissolved in aqueous saturatedpicric acid. Sectionswere then
rapidly washed in running tap water and counterstained with
Harris hematoxylin (Montes 1996). A conventional optical
microscope (BX53Olympusmicroscope, Japan)with a strong
light source (halogen lamp), an analyzer (U-ANT Olympus,
Japan) and a polarizer (U-POT Olympus, Japan) were used
to study the birefringence of the stained collagen.15
Laser Microdissection
Laser microdissection was performed as previously de-
scribed.16 Briefly, intestinal segments were fixed overnight
in zinc-sucrose fixation. Frozen intestinal sections of 15 μm
were obtained with Shandon Cryotome fromThermo Scientific
(Waltham, MA) at −20°C and placed on membrane Slides
PEN-Membrane 2,0 μm (Leica, Germany). Tissue sectionswere
fixed in 70% ethanol for 1 minute stained with haematoxylin
for 30 seconds and putted in 100% ethanol for 1 minute. Cells
fractions from epithelium, muscular layer, and serosa were
obtained with microscope LMD6000 from Leica and col-
lected in lysis buffer for RNA isolation. As average 30 micro-
dissected pieces were collected in a single tube.
TABLE 1.
Rat primers used to evaluate gene expressions
Primer Sequence
qRat IL22 fwd TGG TGC CTT TCC TGA CCA A
qRat IL22 rev GTT CTG GTC ATC ACC GCT GAT
qRat IFNg fwd TAC ACG CCG CGT CTT GGT
qRat IFNg rev GAG TGT GCC TTG GCA GTA ACA G
qRat CXCL1 fwd TGGATGCGTTTCATCGATGGTCGT
qRat CXCL1 rev GCACAGTGGTTGACACCTAATGGT
qRat IDO fwd CAG CAG ATC CTT CAC CAA CG
qRat IDO rev ATC CAG ACA CCT TTT TCC ACG
qRat CXCL10 fwd CTGCACCTGCATCGACTTCC
qRat CXCL10 rev TTCTTTGGCTCACCGCTTTC
qRat IL13 fwd GCA ACA TCA CAC AAG ACC AGA AG
qRat IL13 rev TGT CAG GTC CAC GCT CCA T
qRat actB fwd qRat actB rev CTGACCCATACCCACCATCAC
FIGURE 1. Clinical status of recipients and transplanted intestines
are altered during ACR process. A, quantitative clinical score was
determined for ALLO and ISO ITx recipients. **P<0.01 (B)Worsening
of ALLO group is also reflected in weight loss compared with ISO
group at 10 to 12 days after transplantation. **P < 0.01 (C) Graft tight-
ening (used as clinical rejection indicator) was evident in ALLO group
in contrast with ISO ITx recipients. ****P < 0.001 (N = 10 in each
group for each evaluation).
© 2017 Wolters Kluwer Stringa et al 3RNA Extraction, Reverse Transcription, and
Quantitative Polymerase Chain Reaction
Total RNA extraction from microdissection or whole in-
testinal graft was performed using the NucleoSpin RNA II
kit (GE Healthcare, Aurora, OH). Reverse transcription was
performed using random primers and MMLV-Reverse tran-
scriptase (Invitrogen, Carlsbad, CA). Real-time polymerase
chain reaction was performed following manufacturer's proto-
col using the iCycler thermal cycler (BioRad, Philadelphia,
PA). Primers for rat IL6, IL22, IFNg, CXCL1, IDO, CXCL10,
IL13, and Actin-b were designed by us or adapted from liter-
ature, and their sequences are described in Table 1. Relative
difference calculation using the ΔΔCt method was previ-
ously described.16,17
Nitrosative Stress Determination
Nitrate and nitrite concentration was measured using the
method of Griess on samples previous reducedwith vanadium
hydrochloride according to Miranda et al.18 Quantification
was performed after calibration with standard solutions of
sodium nitrate from Merck Co. (Darmstadt, Germany).
Protein carbonyls (PCs) were determined by the method of
Reznick et al.19 The concentrations of PCs were calcu-
lated from a calibration curve prepared with a stock solution
of sodium pyruvate (Sigma Chem. Co.).
Data Analysis
Continuous variables were analyzed using 1-way analysis
of variance, followed by Dunnett or Tukey posttest. Student
unpaired t test was used to determine the significance of dif-
ferences between 2 groups. TheKaplan-Meiermethodwas used
for actuarial graft survival with comparison using the Log-rank
test. Multivariate analysis of gene expression in early and late
ISO and ALLO intestinal graft was performed. Statistical
analyses were performed using GraphPad software version
5.00 (San Diego, CA). P values less than 0.05 were consid-
ered statistically significant.
RESULTS
Postoperative Clinical Monitoring
ALLO and ISO HITx recipients showed similar clinical
findings associated to the surgical procedure during the first96 hours post-HITx.ISO recipients reached a normal clinical
appearance from the fifth POD, but ALLO recipients worsened
their clinical status with increased ocular/nose secretion and
piloerection as the most characteristic clinical affections.
Statistically significant differences were found between
ISO versus ALLO groups (P < 0.05 at 5 POD and P < 0.01
from sixth to 12th days after ITx) (Figure 1A).
Regarding body weight evaluation after HITx, animals
from both groups lost weight during the first 5 postsurgical
days (media of 12.7 and 21.1% in ISO and ALLO groups).
From sixth to 12th POD, ALLO recipients showed signifi-
cant weight loss in comparison with ISO group, which began
to gain weight and reached their original body weight 10 to
12 POD. Statistically significant differences were found be-
tween ISO versus ALLO groups at 10 to 12 POD (P < 0.01)
(Figure 1b).
Clinical graft rejectiondiagnosedby tighteningof transplanted
intestine was performed. Graft tightening at 7 (3/7), 9 (1/4),
FIGURE 2. Functional features of ALLO intestinal grafts are altered
at early stages of ACR. A, Glucose absorptive capacity was evaluated
by glucose intraluminal administration and evaluation of glucose blood
levels in both early (5 POD) and late (10-12 POD) evaluation times.
Significant differences were observed between ALLO versus ISO and
control groups (intraperitoneal and intestinal intraluminal administration
in nontransplanted animals) 60 and 90 minutes after glucose adminis-
tration. **P < 0.01. Mean and SD values of 6 different independent TX
procedures are depicted. B, barrier function evaluation performed
by plasma OVA determination by ELISA upon administration of OVA
through graft proximal ostomy. Significant differences were observed
in ALLO vs ISO and Sham groups (***P < 0.005). Mean and SD values
of 6 different independent TX procedures are depicted. C, Maximum
contractile strength evaluated by mecanotransduction. Significant dif-
ferences were observed at late stages of ACR between ALLO vs ISO
and control groups. *P < 0.05. Mean and SD values of 6 different
independent TX procedures are depicted.
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ents. ISO group showed no palpable abnormalities. Recipients
survived healthy up to 6months after HITxwithout grafts ab-
normalities. Significant differences in graft survival between
groups were observed (P < 0.001) (Figure 1C).
Graft Functional Evaluation
To evaluate changes in functional graft parameters that are
susceptible to be evaluated in the HITx, a bolus of OVA and
glucose was administered by the proximal ostomy of the graft
and both levels were evaluated at subsequent time points.
Nontransplanted controls were included.
Remarkably, glucose absorption was evident in ISO groups
at 5 and 10 to 12 POD. Glucose levels rise upon administration
reachingmaximum levels at 60 to 90minutes postadministration.
Similar curves were obtained from non-ITx controls, as well
as in ISO group when glucose was administered by intraper-
itoneal route, indicating full absorption of the administered
glucose at the time observed (Figure 2A). Remarkably, in
ALLO groups, at 5 and 10 to 12 POD, glucose levels did not
change from the initial value, indicating lack of absorptive
capacity, even from the initial stages of rejection. Interestingly,
glucose levels were the lowest in ALLO group 10 to 12 POD.
The analysis of plasma levels of OVA at different time
postenteral administration allowed the evaluation of intesti-
nal barrier function. OVAwas detected at very low levels at
different times postadministration in nontransplant controls
as well as in ISO groups (Figure 2b), whereas in the ALLO
groups at 5 post-TX and 10 to 12 POD, OVA passed through
the intestine into the systemic circulation with a plasma mean
value that was higher than 1 μg/mL in all cases, 90 minutes
after administration. This result indicates that even in early
stages of ACR, there is an impairment of barrier function
that is evidenced by passage of nondegraded proteins from
intestinal lumen to blood.
Contractile capacity was also evaluated to determine the
impact of ACR in graft motility. The maximal contractile
strength was diminished in the presence of ACR, being a
trend at 5 POD days toward 10 to 12 days after surgical pro-
cedure, with a statistical significance between ALLO and ISO
groups at 10 to 12 POD (Figure 2C).
Intestinal Graft Histological Evaluation
Samples obtained at 30 minutes postreperfusion showed
the typical ischemia-reperfusion injury lesions, with amedian
Park score of 3 in both groups. Intestinal mucosa recover was
observed in ALLOand ISO groups by PODnumber 3. At this
time of evaluation, samples showed a normal architecture
and no histological alterations were identified (Figure S2,
SDC, http://links.lww.com/TXD/A52).
Graft lesions compatible with ACR were observed since 5
POD in ALLO group. Overall similar results were observed
using the scores described by Wu et al12 and He et al.13 The
former will be used to describe our findings. Mild rejection
was the most characteristic grade of graft rejection. The re-
maining samples showed indeterminate ACR and no signs
of ACR. On the other hand, severe ACR was diagnosed in
all ALLO samples taken at 10 to 12 POD (Figure 3A).
A descriptive evaluation of hematoxylin-eosin staining
intestinal allografts was performed. Samples showed a well-
preserved architecture at 5 to 7 POD. Also, confluent and loose
apoptotic cells in the intestinal epithelium and perivascularinfiltrate in mesenteric vessels andmuscular and serosa layers
were evident (Figure 3B).
Lesions along the transplanted intestines were seen hetero-
geneously at the late phase of ACR. Significant cellular infil-
trate, epithelial damage, absence of enterocytes in some areas
of the graft villi, ulcerated areas and necrosis zones, and in-
crease of apoptotic cells in the entire graft were observed
(Figure 3B).
The muscular layer showed inflammatory cell infiltrate
and increased intercellular edema. Histological changes at
the serosa layer were like those reported at 5 to 7 POD, with
FIGURE 3. Histopathology analysis show evidences of the progression of the ACR process with increasing postoperative time. A, Histologic
diagnosis of ACR and morphologic characteristics in ALLO and ISO groups after ITx (N = 10 in each group for each evaluation time). ALLO
group showed histopathological sign of ACR from the fifth day after transplantation in contrast to ISO group. ***P < 0.005. B. Microscopic graft
appearance in H/E stained intestinal samples of ISO and ALLO ITx groups. C, Apoptotic cell quantification and location in ALLO group evidence
an increase in the number of apoptotic cells in late stages of ACR. **P < 0.01. D, Representative images of early and late stages of ACR in the
ALLO group (20 magnification) by Tunel assay.
© 2017 Wolters Kluwer Stringa et al 5the addition of histological signs compatible with fibrosis
(Figure 3B).
Apoptotic cell evaluation by Tunel technique showed a
progressive increase in allografts from 5 (average of 679.2) to
12 POD (average of 2021) apoptotic cells in 10 analyzed
per sample fields (Figure 3C). Regarding the location of
apoptotic cells, most of them were observed in the lamina
propria (56.3% and 66.6% at 5 POD and 10 to 12 POD,
respectively) and intestinal epithelium (38% and 30% at
5 POD and 10-12 POD, respectively) in all evaluated
sampling times. Apoptotic cells were also observed in crypts
of allografts at different time points (5.62 and 3.33 at 5 POD
and 10-12 POD, respectively) (Figures 3C and D).Gene Expression Analysis
Expression levels of different immune-related genes were
evaluated in full-width graft wall biopsies at different post-
ITx times. At day 5, somemarkers were consistently increased
in ALLO group when compared with ISO controls (Figure 4),
such as CXCL10 that showed a 120 ± 80-fold increase com-
pared with nontransplanted tissue. Furthermore, IFNg and
IDO, which are known to be dependent on IFNg stimulation,
showed a trend to be increased at these timepoints. Remark-
ably, other inflammation-related genes, such as CXCL1 and
IL6 showed consistent increase in ALLO groups at 10 to 12
POD, when severe rejection process was established (Figure 4A).
Interestingly, when a principal component analysis of the
FIGURE 4. Proinflammatory gene expression analysis showed major
differences at later stages of ACR process. A, Relative mRNA intestinal
proinflammatory gene expression at 5 (early) and 10 to 12 (late) days
after ITx in whole intestinal samples in ISO and ALLO groups (N = 6
in each group). Significant differences in terms of IL-6 and CXCL-1
expression were observed between later stages of ACR in ALLO
group vs ISO group. *P < 0.05. B, Principal component analysis of gene
expression profile in ISO andALLO ITx groups at different times after ITX.
The major difference is observed in the ALLO group during the later
stages of ACR.
FIGURE 5. Proinflammatory gene expression was increased in differ-
ent graft tissue layers upon ACR. Epithelial, muscular and serosa layers
were obtained by laser microdissection and gene expression in each
sample was determined by real-time quantitative polymerase chain re-
action (N = 5 for each layer and group). Relative mRNA levels of IL22,
IFNg, CXCL1, IDO, CXCL10, IL13 were evaluated.
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group at 10 to 12 POD clearly separated from the other
conditions (ALLO group at 5 POD and ISO group at both
early and late time points), which were group together
(Figure 4b), indicating that major changes in gene expression
of the immune related genes evaluated was altered mainly in
subsequent stages of ACR.
We wanted to determine if there were differences at the
gene expression level among different graft tissue layers during
ACR. To this aim, we recovered serosa layer, muscular
layer, and epithelial layer using laser dissection microscopy
(Figure S3, SDC, http://links.lww.com/TXD/A52) andmeasured gene expression by quantitative polymerase chain
reaction. Overall results from different layers were coincident
with whole tissue biopsies (Figure 5), where higher levels of
IL6 and CXCL1 were observed in ALLO groups at 10 to 12
POD. Interestingly, IL22 expression was only measurable in
epithelial layer samples in ALLO groups at 10 to 12 POD.
Serosa layer showed some of the highest relative increases in
proinflammatory gene expression also in ALLO groups at 10
to 12 POD (Figure 5).Collagen Determination
To characterize the kinetics of extracellular matrix turn-
over that takes place during the inflammatory processes,
collagen type I and type III were determined by the Picrosirius
staining technique.We observed that the type I/type III ratio in-
creased in ALLO group at days 10 to 12 post-TX, indicating
extensive remodelling (Figure 6).
FIGURE 6. Collagen type I/III increase considerably in ALLO group after 10 to 12 days after ITX compared with ALLO (N = 6) early and early
and late ISO groups (N = 6). **P < 0.01. Also, representative microscopic images of different collagen types are shown.
FIGURE 7. A, Nitrites plasma levels increase from initial stages to late
phases of ACR process. Significant differences were observed between
ALLO (N = 6) vs ISO (N = 6) and basal nitrites levels. **P < 0.01. B,
Plasma levels of protein carbonyls only increase significantly in later
phases of ACR in ALLO group. *P < 0.05.
© 2017 Wolters Kluwer Stringa et al 7Plasma Nitrites Levels Increased From the Early
Stages of Rejection Process
To follow the kinetics of putative plasmatic biomarkers of
rejection, nitrites and protein carbonyls were evaluated at
different time points. Nitrites plasma levels considerably
increased in ALLO recipients. The highest levels of nitrites
were observed at the early ACR phase, with an average of
568.1 ± 185.4 (P < 0.05 vs baseline). During the late phase
of ACR, elevated levels of plasma nitrites were also observed
(558.7 ± 200.0), being statistically significant compared to
baseline (69.5 ± 22.2 mU/mL) as well as to ISO group. This
group showed similar values to baseline in both sampling
times, with an average of 118.0 ± 54.6 mU/mL and
65.2 ± 15.0 mU/mL in the early and late measurements re-
spectively (Figure 7A).
A significant increase in plasma levels of protein carbonyls
was only observed in the late phase of the ACR process. Al-
though ALLO group showed an average of 0.0057mmol/μg,
the average baseline was 0.0032 (P < 0.05) (Figure 7b).
DISCUSSION
We performed a HITx model using a previously reported
strain combination. The model using an outbreed strain
reproduced the major histopathological findings of clinical
rejection, allowing to see in the animal the dynamic process
observed in the clinical setting.20 Although all results shown
were obtained using Sprague Dawley donors into Wistar re-
cipients, the reverse combination produced similar results at
the histopathological levels (previously reported). The use
of the heterotopic technique without immunosuppression
lead to an overt ACR that progress to severe exfoliative rejec-
tion in 10 to 14 days, which is similar to other reports using
different strain combinations21-23 Interestingly, we observed
immunological activity with infiltration (Figure 3) and collagen
turnover (Figure 6) in different tissue layers, mucosa, muscular,
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affects all tissue layers. During the clinical monitoring, the use
of mucosal biopsies has provided extensive information on the
changes affecting graft mucosa, during rejection episodes, being
the gold standard method for patient follow-up, because deeper
layers cannot be biopsied due to methodological limitations.24
However, the evidence that ACR compromises other tissue
layers, not only the mucosa, could be proved in these
model, were the histology (Figure 3) as well as in the gene
expression tests (Figure 5), provide information on these regard
and might suggest, in the future, new possible molecules
to be used as early rejection biomarkers, field in which
epithelial-related biomarker were dominant, such as citrulline
or fatty acid binding protein.25,26
Our results also demonstrate the early activation of IFNg
axis during ACR process, because at early time points (5 days
post-ITx), there is an increase of expression of IFNg-related
genes, such as CXCL10 and IDO. Those results are coinci-
dent with the rise in circulatory levels of nitrites (Figure 7),
because of M1 macrophage activation and NO production,
which is also associated to IFNg axis. Their role in the
pathophysiology of ACR has also been reported.27 These
results validate previous reports, indicating that IFNg is a
crucial driver of ACR in ITx.28,29
One interesting finding of our experiments is the early loss
of graft functional capacity as ACR progress. We used very
simple techniques with tracers that could be easily translated
to a clinical setup, such as glucose testing and OVA evalua-
tion by ELISA. It has been previously reported that monosac-
charide absorption capacity is impaired by ACR in rodent
ITxmodels by 14 POD.30 In our set of experiments, we could
determine that loss of absorptive capacity for glucose is an
early feature of ACR, because when only mild alterations
were detected by histopathological analysis, the glucose ab-
sorption was completely blunted to levels similar to observed
at severe exfoliative rejection (Figure 2). This could be due
to the fact that glucose is normally absorbed through the
transcellular route after an active process that requires
enterocyte energy fitness. Although not fully elucidated at
the cellular and molecular levels, there is consensus that
alloactivation of CD4 and CD8 lymphocytes is the main
driver of graft rejection, with enterocytes being one of the
main targets.31 Increase in crypt enterocyte apoptosis is 1
characteristic feature of small bowel rejection.32-34 Glucose
absorption takes place in villous epithelium, consequently,
our observation may indicate that villous enterocytes are
also affected by initial rejection events. Lymphocytes suffer
from several important metabolic changes upon activation,
with an increase in glycolysis being one of the most constant
features.35 Consequently, increased local glucose consumption
by activated lymphocytes in the rejecting graft may also
contribute to the lack of increment in glucose levels in
peripheral circulation.
On the other hand, the use of enteral OVA administration
allowed determining the loss of barrier function. In physio-
logical situations, ingested proteins are almost completely
degraded along the gastrointestinal tract, and only a minimal
fraction can reach the systemic compartment as nondegraded
protein by passage through paracellular route.36-38 We
confirmed that either in nontransplanted animals, the ad-
ministration of enteral OVA does not result in presence of im-
munoreactive OVA in circulation at either 30 or 90 minutespostadministration. These findings indicate the integrity of in-
testinal barrier (Figure 2). Interestingly, in ISO TX controls at
5 to 7 days posttransplant, low, but detectable, levels of OVA
were assessed, with a trend to show higher levels of OVA
compared with ISO controls at later time points. These results
could be due to some permeability differences accounting for
incomplete barrier reparation upon transplant operation or to
denervation performed for transplantation or both. On the
other hand, even at 5 POD, when only mild histopathological
changes were detected, enteral administered OVA reach
the circulation, resulting in levels higher than 1 μg/mL,
indicating leakage of the intestinal barrier caused by ACR.
The seminal work of Grant et al5 have shown increase in
graft permeability in HITx model using the administration of
ethylenediaminetetraacetic acid 51Cr by enteral route and
urinary excretion as measurement of barrier dysfunction.
Although the tracer used by Grant et al is different than the
tracer that we used, results are coincident, indicating the loss
of barrier function during ACR process. In our study, the
kinetics indicates that this is an early feature of ACR. The loss
of barrier function and the putative passage of microbiota-
derived biomolecules have been proposed as an amplification
mechanism that contributes to increase inflammation along
ACR process.30 Our results indicate that this mechanism is
operating since the early stages of ACR process, which may
provide the rationale for early therapeutic interventions in
the clinics. In the clinical setting, our group showed that
albumin levels in plasma can be used as a tool to assess
mucosal barrier recovery after severe exfoliative rejection.39
From the beginning of ITx, it has been observed in the clin-
ical practice that the development of ACR is associated with
a progressive reduction of the intestinal motility to the point
that significant ileus is observed in moderate and severe re-
jection, and the functional motility recovery is also a clini-
cal indicator of recovery.33 This observation has been also
described in animal models, finding a correlation with the
severity of rejection and the participation of muscle layer
myeloid cells in the physiopathology of the alteration.40
We also observed a correlation between ACR progression and
loss of contractile capacity (Figure 2). Although our model has
several limitations compared with the clinical ITx process of
rejection itself, and currently lacks immunosuppressive therapy,
it is an adequate model to start building knowledge. As it
was mentioned, the main aim of the work was achieved: a
rejection ITx rat model that further allows studying dynamic
phenomena related with ACR at the different layers of the
intestinal graft was established. We further observed an
early rise in plasma nitrites associated to ACR progression
(Figure 7), which was also shown in the clinical setting; and a
late rise in plasma protein carbonyls that are produced during
acute inflammatory processes that takes place in advanced
stages of rejection (Figure 6).41Concluding Remarks
In summary, we observed that functional features of the
graft, such as glucose and OVA absorption, are altered at
early stages of ACR, suggesting that they could be interesting
parameters to evaluate in the clinical setting to provide
additional tools for rejection diagnosis. The model provides
a consistent kinetic that may allow to study not only the
immunobiology of the ACR process but also to further study
© 2017 Wolters Kluwer Stringa et al 9intervention strategies and search for biomarkers that could
be translated to the clinical setting.
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